Pasithea Therapeutics(KTTA.US)

最近更新時間 19:00:00 美東
longbridge loading

Pasithea Therapeutics 任命 Kartik Krishnan 為首席醫療官（CMO）

rttnews·
US
KTTAW
-38.67%
US
KTTA
+2.76%
US
標普全球醫療...
+0.35%
rttnews·
US
KTTAW
-38.67%
US
KTTA
+2.76%
US
標普全球醫療...
+0.35%

美股盤前熱門交易：Pasithea Therapeutics 任命新首席醫療官，盤前股價漲 7.02% 引市場關注

異動追蹤·
US
KTTA
+2.76%
異動追蹤·
US
KTTA
+2.76%

Pasithea Therapeutics 宣佈任命 Kartik Krishnan 博士為首席醫療官 | KTTA 股票新聞

StockTitan·
US
KTTAW
-38.67%
US
KTTA
+2.76%
US
標普生物技術...
+11.76%
StockTitan·
US
KTTAW
-38.67%
US
KTTA
+2.76%
US
標普生物技術...
+11.76%

Pasithea Therapeutics 宣佈 FDA 授予 PAS-004 用於治療神經纖維瘤病 1 型（NF1）的罕見兒科疾病認定（RPDD）| KTTA 股票新聞

StockTitan·
US
KTTAW
-38.67%
US
KTTA
+2.76%
US
紐交所高增長...
+2.14%
StockTitan·
US
KTTAW
-38.67%
US
KTTA
+2.76%
US
紐交所高增長...
+2.14%

美股盤前熱門交易：Greenland Energy 盤前漲 9.13%；Pasithea Therapeutics 盤前跌 8.60%

異動追蹤·
US
GLND
-1.79%
US
KTTA
+2.76%
異動追蹤·
US
GLND
-1.79%
US
KTTA
+2.76%

MindBio 宣佈完成私募配售

The newswire.ca·
US
NBSE.ESC
0.00%
US
BTMD
+6.33%
US
醫藥突破 ETF...
+3.75%
The newswire.ca·
US
NBSE.ESC
0.00%
US
BTMD
+6.33%
US
醫藥突破 ETF...
+3.75%

Pasithea Therapeutics｜10-K：2025 財年營收 0 美元

長灣財報·
US
KTTA
+2.76%
長灣財報·
US
KTTA
+2.76%

MindBio 宣佈將私人配售規模擴大至最高 150 萬美元

The newswire.ca·
US
IBBQ
+2.43%
US
紐交所高增長...
+2.14%
US
2 倍做多納斯...
+4.98%
The newswire.ca·
US
IBBQ
+2.43%
US
紐交所高增長...
+2.14%
US
2 倍做多納斯...
+4.98%
© 2026 Longbridge｜免責聲明